Nuclear and cytoplasmic expressions of ER beta 1 and ER beta 2 are predictive of response to therapy and alters prognosis in familial breast cancers
Max Yan, Mukta Rayoo, Elena A Takano, Stephen B Fox
Breast Cancer Research and Treatment | SPRINGER | Published : 2011
Awarded by National Health and Medical Research Council (NHMRC)
We wish to thank Heather Thorne, Eveline Niedermayr, the kConFab research nurses and staff, the staff and of the Family Cancer Clinics, the Clinical Follow Up Study (funded by NHMRC Grants 145684, 288704 and 454508). kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. This study was partly funded by the Victorian Breast Cancer Research Consortium, the NHMRC, the Royal College of Pathologists of Australasia and the Victorian Cancer Biobank.